Deals agreed as Infex’s resistance bypass drug program heads for clinic

Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help…


Infex focuses on pandemic preparedness with Covid patent

Infex Therapeutics has filed for a UK patent for a novel therapy designed to…


Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs

Infex Therapeutics has combined forces with medical research charity, LifeArc,…


Introducing Infex Therapeutics

The organisation leading UK efforts to tackle the health crisis around our…


The AMR Centre signs agreement to co-develop treatment for gonorrhoea

The AMR Centre (AMRC) has today announced a multi-year co-development…


AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK The AMR Centre has nominated a preclinical candidate in…


The AMR Centre set for partnership with Shionogi for new superbug therapy

The AMR Centre Ltd has today announced a landmark agreement with the Japanese…


The AMR Centre secures £2.3m funding boost

The AMR Centre, a body with public and private investors leading the UK’s…